383 related articles for article (PubMed ID: 30219612)
1. Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
Popp I; Bott S; Mix M; Oehlke O; Schimek-Jasch T; Nieder C; Nestle U; Bock M; Yuh WTC; Meyer PT; Weber WA; Urbach H; Mader I; Grosu AL
Radiother Oncol; 2019 Jan; 130():121-131. PubMed ID: 30219612
[TBL] [Abstract][Full Text] [Related]
2. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
3. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
4. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
[TBL] [Abstract][Full Text] [Related]
5. FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Carles M; Popp I; Starke MM; Mix M; Urbach H; Schimek-Jasch T; Eckert F; Niyazi M; Baltas D; Grosu AL
Radiat Oncol; 2021 Mar; 16(1):46. PubMed ID: 33658069
[TBL] [Abstract][Full Text] [Related]
6. Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
Harat M; Małkowski B; Makarewicz R
Radiother Oncol; 2016 Aug; 120(2):241-7. PubMed ID: 27378734
[TBL] [Abstract][Full Text] [Related]
7. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
8. Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
Rahm V; Boxheimer L; Bruehlmeier M; Berberat J; Nitzsche EU; Remonda L; Roelcke U
J Nucl Med; 2014 Apr; 55(4):546-50. PubMed ID: 24566001
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
10. Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
Piroth MD; Galldiks N; Pinkawa M; Holy R; Stoffels G; Ermert J; Mottaghy FM; Shah NJ; Langen KJ; Eble MJ
Radiat Oncol; 2016 Jun; 11():87. PubMed ID: 27342976
[TBL] [Abstract][Full Text] [Related]
11. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Fleischmann DF; Unterrainer M; Corradini S; Rottler M; Förster S; la Fougère C; Siepmann T; Schwaiger M; Bartenstein P; Belka C; Albert NL; Niyazi M
PLoS One; 2019; 14(7):e0216111. PubMed ID: 31339892
[TBL] [Abstract][Full Text] [Related]
12. 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
Plotkin M; Gneveckow U; Meier-Hauff K; Amthauer H; Feussner A; Denecke T; Gutberlet M; Jordan A; Felix R; Wust P
Int J Hyperthermia; 2006 Jun; 22(4):319-25. PubMed ID: 16754352
[TBL] [Abstract][Full Text] [Related]
13. The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.
Badakhshi H; Graf R; Prasad V; Budach V
Cancer Imaging; 2014 Jun; 14(1):25. PubMed ID: 25608761
[TBL] [Abstract][Full Text] [Related]
14. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
15. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
[TBL] [Abstract][Full Text] [Related]
16. Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.
Vees H; Senthamizhchelvan S; Miralbell R; Weber DC; Ratib O; Zaidi H
Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):182-93. PubMed ID: 18818918
[TBL] [Abstract][Full Text] [Related]
17. Increasing the accuracy of volume and ADC delineation for heterogeneous tumor on diffusion-weighted MRI: correlation with PET/CT.
Gong NJ; Wong CS; Chu YC; Guo H; Huang B; Chan Q
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):407-13. PubMed ID: 23958150
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of
Moller S; Law I; Munck Af Rosenschold P; Costa J; Poulsen HS; Engelholm SA; Engelholm S
Radiother Oncol; 2016 Oct; 121(1):132-137. PubMed ID: 27622554
[TBL] [Abstract][Full Text] [Related]
19. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
20. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
